You searched for "neuroretinopathy"

554 results found

A scoping review of artificial intelligence tools for diabetic retinopathy in low- and middle-income countries

The authors conducted a scoping review to summarise the literature relating to artificial intelligence (AI) tools for diabetic retinopathy (DR) in low- and middle-income countries (LMICs). Eighty-one studies were included, following a comprehensive literature search. The majority of studies were...

Providing well-developed education materials can improve follow-up attendance for retinopathy of prematurity screening

he authors present a repeated measures study with parents of children at risk of developing retinopathy of prematurity (ROP). Inclusion criteria for the study was parents with children born at <32 weeks or with a birth weight under 1.5kg. Participants...

Associations with health disparities for eyecare in the USA

The purpose of this study was to explore the association between race and socioeconomic status (SES) on health disparities in paediatric eyecare, to characterise the status of diversity within the paediatric ophthalmology workforce and to propose potential solutions to improve...

What factors influence attendance at retinopathy of prematurity screening follow-up?

The authors present a retrospective medical notes review of babies attending outpatient appointments for retinopathy of prematurity (ROP) examination, over a 12-month period. The aim of the study was to assess compliance with these appointments at a single centre. Data...

Binocular Indirect Ophthalmoscopy Training Workshop – NHS Fife, Scotland

Join leading ophthalmology educator Dr. Andrew Blaikie for a one-day BIO Workshop at FORGE, Queen Margaret Hospital, Dunfermline. This hands-on course using the new Arclight BIO is ideal for ophthalmology trainees. Learn to examine retinal disease, including diabetic retinopathy and...

Fenofibrate and diabetic retinopathy

Fenofibrate is an agonist of peroxisome proliferator-activated receptor-alpha (PPARα) which is used as a lipid-lowering agent. By reducing blood lipid levels, it can decrease retinal hard exudates which is beneficial in diabetic retinopathy (DR). FIELD and ACCORD studies show that...

Overview of RoP in a Cyprus population

This was the first epidemiology study of retinopathy of prematurity (RoP) in Cyprus, aiming to validate their criteria for RoP screening. This involved a retrospective review of discharge letters of all infants in RoP screening from January 2023 to December...

To involve or not to involve parents in the RoP examination of infants

This study investigated whether allowing parents to witness retinopathy of prematurity (RoP) examinations influences their levels of anxiety, depression and hopelessness, in addition to potential differences in psychological outcomes between parents of infants with and without RoP, and between fathers...

Randomisation, confounding & observational methods in ophthalmic epidemiology

Randomisation and confounding Understanding the relationship between an exposure and an outcome of interest is the central challenge in ophthalmic epidemiology. The exposure may be aetiological, taking the form of a putative risk biological factor, or therapeutic, in the form...

Leveraging networks and collaboration: The Calabar Diabetic Retinopathy Service, from inception to a state-wide service, research and training hub

Diabetic retinopathy (DR), a microvascular complication of diabetes mellitus (DM), is a leading cause of preventable vision loss and blindness in people of working age globally [1]. Diabetic retinopathy is a disease of public health importance in Nigeria as it...

Addressing diabetes-related complications in Tanzania and Eswatini: A comprehensive approach to eye and foot screening

Diabetes is rising globally, particularly in low- to middle-income countries (LMICs), where healthcare systems are under resourced [1,2]. Among its complications, diabetic retinopathy (DR) and diabetic foot disease are preventable yet frequently overlooked [3-6]. These problems often develop together due...

Advances and developments in medical retina

The author provides an update on late breaking clinical trial results in neovascular age-related macular degeneration (nAMD) and presentations on diabetes management from the American Academy of Ophthalmology Retina Subspecialty Day, held during the Academy’s annual meeting in Chicago, October...